| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $6.02B | -6.3% |
| R&D Expense | $360.3M | -1.4% |
| SG&A Expense | $208.1M | -27.9% |
| Operating Income | -$589.4M | -19.6% |
| Interest Expense | $3.6M | +50.0% |
| Pre-tax Income | -$602.4M | -21.3% |
| Income Tax | -$900K | +64.0% |
| Net Income | -$601.5M | -21.7% |
| EPS (Basic) | -$1.40 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $361.9M | -41.5% |
| Accounts Receivable | $36.6M | -24.5% |
| Current Assets | $517.9M | -34.8% |
| Total Assets | $1.53B | -14.9% |
| Current Liabilities | $517.5M | +18.4% |
| Total Liabilities | $1.01B | +6.2% |
| Stockholders' Equity | $517.1M | -38.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$291.7M | -919.9% |
| Capital Expenditures | $70.1M | +39.9% |
| Investing Cash Flow | -$100.1M | +48.0% |
| Financing Cash Flow | $135.4M | -66.1% |
| Free Cash Flow | -$361.8M | -359.7% |
| +7.3% |
| EPS (Diluted) | -$1.40 | +7.3% |